Global Phelan McDermid Syndrome Market, By Drugs & Diagnostic Technologies (Chromatin Structures, Micro RNA Modification, Large Non-Coding RNA, Histone Acetylation, Histone Methylation, DNA Methylation), Diagnosis (Chromosomal Microarray Analysis (CMA), Single-Gene Testing, Whole Exome Sequencing (WES)), End-Users (Hospitals, Homecare, Specialty Clinics), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028